History
2015.7
Established at 1-27-11, Shibuya, Shibuya-ku, Tokyo as a subsidiary specializing in medical equipment of Allm Inc..
2016.3
Capital increased to 10,200 million yen due to business expansion.
2016.3
Selected by the Japan Agency for Medical Research and Development (AMED) for its Medical Device Development Promotion Research Program, which aims to develop and commercialize innovative medical devices through physician-led clinical trials, etc., and to out-license the results to companies.
【国産初流体解析に基づいた脳動脈瘤治療用セミカスタムメイドステントの医師主導治験】
2016.4
Approved Type 1 medical device manufacturing and sales business and manufacturing business. (Tokyo)
2017.3
Increased capital to 198 million yen due to business expansion.
2018.3
Capital increased to 21,000 million yen due to business expansion.
2018.10
Increased capital to 25,800 million yen due to business expansion.
2018.11
Japan Agency for Medical Research and Development (AMED) Physician-Initiated Clinical Trials Additional Accelerated Expenses Accepted.
2019.9
Capital increased to 28,200 million yen due to business expansion.
2021.11
Moved to 1-12-1 Dogenzaka, Shibuya-ku, Tokyo (change of manufacturing address)
2023.2
PENTAS Microcatheters PMDA approved.
2023.3
Reduced capital to 10 million yen as capital policy.
2023.8
Increased capital to 158.5 million yen due to business expansion.
2023.10
Established PENTAS Laboratory in Tonomachi, Kawasaki City (CYBERNICS MEDICAL INNOVATION BASE-A)
2024.3
Reduced capital to 10 million yen as capital policy.
2024.4
2025.9
In line with business expansion, the capital was increased to 146.5 million yen.
2025.2
Obtained a license for the sales of Class I, II, and IV medical devices. (License No. 0715367)
2025.4
Excluded from the consolidated subsidiaries of Allm Inc. and became part of the GENARK Inc. group.
2025.12
Obtained ISO13485 certification